{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:43:37Z","timestamp":1793187817575,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Older adults often use multiple medicines to manage comorbidities well or to prevent associated complications. This study aims to determine polypharmacy, the use of potentially inappropriate medications (PIMs) using the 2019 Beers Criteria and to determine the Medication Regimen Complexity Index (MRCI) score. It also aims to identify factors associated with the presence of PIMs and the MRCI score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study was carried out between 6 and 2023 and 5 May 2023 in a community pharmacy in Turkey. Elderly patients over 65 years of age, who used at least one drug, and who came to the pharmacy for any reason were included in the study. PIMs were determined according to the 2019 Beers Criteria. The Turkish validated version of the MRCI was used to determine the medication complexity score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>200 patients were included in this study. 59.5% of the patients were female and the median age was 70 (IQR, 66-74.75). Polypharmacy was detected in 33% of patients. The use of PIMs was determined in 63.5% of the patients. The median of the MRCI score was 11 (IQR, 7\u201315). The number of chronic diseases and drugs, presence of polypharmacy, MRCI score and mental disorders were found to be significantly higher in those with PIMs than in those without (p\u2009&lt;\u20090.05). Having less than eight years of education, presence of polypharmacy, the presence of comorbidity (diabetes mellitus, cardiovascular disease, thyroid, chronic obstructive pulmonary disease (COPD), asthma and mental disorders) were associated with significantly higher MRCI scores (p\u2009&lt;\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>According to the results of our study, it was found that the elderly patients who came to the pharmacy had low MRCI scores, but had high PIMs use. Community pharmacists have an important role in identifying inappropriate drug use, so they should be trained to develop skills in identifying and reducing PIMs in older patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-023-04381-4","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:02:08Z","timestamp":1697176928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-4746","authenticated-orcid":false,"given":"Asl\u0131nur","family":"Albayrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Demirba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"4","key":"4381_CR1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/jgs.14077","volume":"64","author":"M Jir\u00f3n","year":"2016","unstructured":"Jir\u00f3n M, Pate V, Hanson LC, Lund JL, Jonsson Funk M, St\u00fcrmer T. Trends in prevalence and determinants of potentially inappropriate prescribing in the United States: 2007 to 2012. J Am Geriatr. 2016;64(4):788\u201397.","journal-title":"J Am Geriatr"},{"key":"4381_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1\u201310.","journal-title":"BMC Geriatr"},{"key":"4381_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11096-020-01139-5","volume":"43","author":"D He","year":"2021","unstructured":"He D, Zhu H, Zhou H, Dong N, Zhang H. Potentially inappropriate medications in Chinese older adults: a comparison of two updated Beers criteria. Int J Clin Pharm. 2021;43:229\u201335.","journal-title":"Int J Clin Pharm"},{"key":"4381_CR4","doi-asserted-by":"crossref","first-page":"204209861982943","DOI":"10.1177\/2042098619829431","volume":"10","author":"D Curtin","year":"2019","unstructured":"Curtin D, Gallagher PF, O\u2019Mahony D. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019;10:2042098619829431.","journal-title":"Ther Adv Drug Saf"},{"key":"4381_CR5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"American Geriatrics Society","year":"2019","unstructured":"American Geriatrics Society. 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"4381_CR6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","volume":"151","author":"MH Beers","year":"1991","unstructured":"Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151(9):1825\u201332.","journal-title":"Arch Intern Med"},{"key":"4381_CR7","unstructured":"American Geriatrics Society. 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023."},{"issue":"1","key":"4381_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jgs.13229","volume":"63","author":"K Hagstrom","year":"2015","unstructured":"Hagstrom K, Nailor M, Lindberg M, Hobbs L, Sobieraj DM. Association between potentially inappropriate medication use in elderly adults and hospital-related outcomes. J Am Geriatr Soc. 2015;63(1):185\u201386.","journal-title":"J Am Geriatr Soc"},{"key":"4381_CR9","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1590\/1413-81232021268.05672020","volume":"26","author":"MFS Praxedes","year":"2021","unstructured":"Praxedes MFS, Pereira GCS, Lima CFM, Santos DBd, Berhends JS. Prescribing potentially inappropriate medications for the elderly according to Beers Criteria: systematic review. Cien Saude Colet. 2021;26:3209\u201319.","journal-title":"Cien Saude Colet"},{"issue":"2","key":"4381_CR10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/glw140","volume":"72","author":"E Wallace","year":"2017","unstructured":"Wallace E, McDowell R, Bennett K, Fahey T, Smith SM. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(2):271\u201377.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"4381_CR11","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1002\/hsr2.214","volume":"3","author":"B Chahine","year":"2020","unstructured":"Chahine B. Potentially inappropriate medications prescribing to elderly patients with advanced chronic kidney by using 2019 American Geriatrics Society Beers Criteria. Health Sci Rep. 2020;3(4):e214.","journal-title":"Health Sci Rep"},{"key":"4381_CR12","doi-asserted-by":"crossref","unstructured":"Xu Z, Liang X, Zhu Y, Lu Y, Ye Y, Fang L et al. Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic review. Fam Med Community Health. 2021;9(4).","DOI":"10.1136\/fmch-2021-001325"},{"key":"4381_CR13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11096-015-0125-0","volume":"37","author":"E Alhmoud","year":"2015","unstructured":"Alhmoud E, Khalifa S, Bahi AA. Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar. Int J Clin Pharm. 2015;37:815\u201321.","journal-title":"Int J Clin Pharm"},{"key":"4381_CR14","doi-asserted-by":"crossref","unstructured":"Zeenny R, Wakim S, Kuyumjian Y-M. Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteria. Clin Interv Aging. 2017:65\u201373.","DOI":"10.2147\/CIA.S87564"},{"key":"4381_CR15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s11096-014-9963-4","volume":"36","author":"AM Advinha","year":"2014","unstructured":"Advinha AM, de Oliveira-Martins S, Mateus V, Pajote SG, Lopes MJ. Medication regimen complexity in institutionalized elderly people in an aging society. Int J Clin Pharm. 2014;36:750\u201356.","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"4381_CR16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","volume":"17","author":"JW Wastesson","year":"2018","unstructured":"Wastesson JW, Morin L, Tan EC, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185\u201396.","journal-title":"Expert Opin Drug Saf"},{"key":"4381_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11096-016-0409-z","volume":"39","author":"AM Advinha","year":"2017","unstructured":"Advinha AM, Lopes MJ, de Oliveira-Martins S. Assessment of the elderly\u2019s functional ability to manage their medication: a systematic literature review. Int J Clin Pharm. 2017;39:1\u201315.","journal-title":"Int J Clin Pharm"},{"key":"4381_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11096-014-0063-2","volume":"37","author":"C Silva","year":"2015","unstructured":"Silva C, Ramalho C, Luz I, Monteiro J, Fresco P. Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention. Int J Clin Pharm. 2015;37:327\u201334.","journal-title":"Int J Clin Pharm"},{"issue":"16","key":"4381_CR19","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.3390\/ijerph18168824","volume":"18","author":"C Falch","year":"2021","unstructured":"Falch C, Alves G. Pharmacists\u2019 role in older adults\u2019 medication regimen complexity: a systematic review. Int J Environ Res Public Health. 2021;18(16):8824.","journal-title":"Int J Environ Res Public Health"},{"key":"4381_CR20","unstructured":"Kelley SO. Measurement of the complexity of medication regimens of the elderly. University of Missouri-Columbia; 1988."},{"issue":"3","key":"4381_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01376517-200306000-00005","volume":"35","author":"C DiIorio","year":"2003","unstructured":"DiIorio C, Yeager K, Shafer PO, Letz R. The Epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs. 2003;35(3):155.","journal-title":"J Neurosci Nurs"},{"issue":"1","key":"4381_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jana.2005.11.003","volume":"17","author":"C DiIorio","year":"2006","unstructured":"DiIorio C, McDonnell M, McCarty F, Yeager K. Initial testing of the antiretroviral medication complexity index. J Assoc Nurses AIDS Care. 2006;17(1):26\u201336.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"9","key":"4381_CR23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","volume":"38","author":"J George","year":"2004","unstructured":"George J, Phun Y-T, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369\u201376.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"4381_CR24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jep.12526","volume":"22","author":"B Okuyan","year":"2016","unstructured":"Okuyan B, Babi B, Sancar M, Ay P, Y\u00fccel E, Y\u00fccel A, et al. Validation of the Turkish version of medication regimen complexity index among elderly patients. J Eval Clin Pract. 2016;22(5):732\u201336.","journal-title":"J Eval Clin Pract"},{"issue":"4","key":"4381_CR25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1060028019886846","volume":"54","author":"V Alves-Concei\u00e7\u00e3o","year":"2020","unstructured":"Alves-Concei\u00e7\u00e3o V, Rocha KSS, Silva FVN, Silva RdOS, Cerqueira-Santos S, Nunes MAP, et al. Are clinical outcomes associated with medication regimen complexity? A systematic review and meta-analysis. Ann Pharmacother. 2020;54(4):301\u201313.","journal-title":"Ann Pharmacother"},{"key":"4381_CR26","doi-asserted-by":"crossref","first-page":"205031211663242","DOI":"10.1177\/2050312116632426","volume":"4","author":"N Abou-Karam","year":"2016","unstructured":"Abou-Karam N, Bradford C, Lor KB, Barnett M, Ha M, Rizos A. Medication regimen complexity and readmissions after hospitalization for Heart Failure, acute Myocardial Infarction, Pneumonia, and Chronic Obstructive Pulmonary Disease. SAGE Open Med. 2016;4:2050312116632426.","journal-title":"SAGE Open Med"},{"issue":"1","key":"4381_CR27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1060028013510898","volume":"48","author":"MN Willson","year":"2014","unstructured":"Willson MN, Greer CL, Weeks DL. Medication regimen complexity and hospital readmission for an adverse drug event. Ann Pharmacother. 2014;48(1):26\u201332.","journal-title":"Ann Pharmacother"},{"key":"4381_CR28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10620-016-4391-z","volume":"62","author":"SZ Kuo","year":"2017","unstructured":"Kuo SZ, Haftek M, Lai JC. Factors associated with medication non-adherence in patients with end-stage Liver Disease. Dig Dis Sci. 2017;62:543\u201349.","journal-title":"Dig Dis Sci"},{"key":"4381_CR29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00228-015-1883-2","volume":"71","author":"BC Wimmer","year":"2015","unstructured":"Wimmer BC, Johnell K, Fastbom J, Wiese MD, Bell JS. Factors associated with medication regimen complexity in older people: a cross-sectional population-based study. Eur J Clin Pharmacol. 2015;71:1099\u2013108.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"4381_CR30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eurger.2015.10.003","volume":"6","author":"M Herson","year":"2015","unstructured":"Herson M, Bell J, Tan E, Emery T, Robson L, Wimmer B. Factors associated with medication regimen complexity in residents of long-term care facilities. Eur Geriatr Med. 2015;6(6):561\u201364.","journal-title":"Eur Geriatr Med"},{"issue":"2","key":"4381_CR31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bcp.14947","volume":"88","author":"I Bu\u017ean\u010di\u0107","year":"2022","unstructured":"Bu\u017ean\u010di\u0107 I, Kummer I, Dr\u017eai\u0107 M, Ortner Had\u017eiabdi\u0107 M. Community-based pharmacists\u2019 role in deprescribing: a systematic review. Br J Clin Pharmacol. 2022;88(2):452\u201363.","journal-title":"Br J Clin Pharmacol"},{"key":"4381_CR32","doi-asserted-by":"crossref","unstructured":"Yakar M, \u00d6zg\u00fcr EM. T\u00fcrkiye\u2019de N\u00fcfus Ya\u015flanmas\u0131, Yerel D\u00fczeyde Tehlike \u00c7anlar\u0131 \u00c7al\u0131yor. Co\u011frafya Derg. 2022(44):231\u201350.","DOI":"10.26650\/JGEOG2022-1059215"},{"key":"4381_CR33","unstructured":"T\u00dc\u0130K. (2022). \u0130statistiklerle Ya\u015fl\u0131lar, 2022. Available from: https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=%C4%B0statistiklerle-Ya%C5%9Fl%C4%B1lar-2022-49667&dil=1. Accessed 19 Aug 2023."},{"key":"4381_CR34","unstructured":"Raosoft Inc. (2004) RaoSoft\u00ae sample size calculator. Available from: http:\/\/www.raosoft.com\/samplesize.html. Accessed 01 Jun 2022."},{"key":"4381_CR35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12:443\u201352.","journal-title":"Eur Geriatr Med"},{"key":"4381_CR36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s11096-018-0663-3","volume":"40","author":"LC Chiapella","year":"2018","unstructured":"Chiapella LC, Montemarani Menna J, Mamprin ME. Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation. Int J Clin Pharm. 2018;40:987\u201390.","journal-title":"Int J Clin Pharm"},{"key":"4381_CR37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s40266-013-0073-0","volume":"30","author":"E Blozik","year":"2013","unstructured":"Blozik E, Rapold R, von Overbeck J, Reich O. Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland. Drugs Aging. 2013;30:561\u201368.","journal-title":"Drugs Aging"},{"issue":"4","key":"4381_CR38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/2010105819868485","volume":"28","author":"YW Tan","year":"2019","unstructured":"Tan YW, Suppiah S, Bautista MAC, Malhotra R. Polypharmacy among community-dwelling elderly in Singapore: prevalence, risk factors and association with medication non-adherence. Proc Singap Healthc. 2019;28(4):224\u201331.","journal-title":"Proc Singap Healthc"},{"issue":"2","key":"4381_CR39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/17843286.2020.1829251","volume":"77","author":"Z Say\u0131n","year":"2022","unstructured":"Say\u0131n Z, Sancar M, \u00d6zen Y, Okuyan B. Polypharmacy, potentially inappropriate prescribing and medication complexity in Turkish older patients in the community pharmacy setting. Acta Clin Belg. 2022;77(2):273\u201379.","journal-title":"Acta Clin Belg"},{"key":"4381_CR40","unstructured":"\u00d6zt\u00fcrk GZ, Ardic C, Toprak D. Frequency of polypharmacy and use of potentially inappropriate medications in the elderly. Turk J Geriatr. 2017;20(4)."},{"issue":"2","key":"4381_CR41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cger.2012.01.001","volume":"28","author":"B Hovstadius","year":"2012","unstructured":"Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28(2):159\u201372.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"4381_CR42","first-page":"32","volume":"100","author":"AD Halli-Tierney","year":"2019","unstructured":"Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100(1):32\u20138.","journal-title":"Am Fam Physician"},{"issue":"1","key":"4381_CR43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/agm2.12194","volume":"5","author":"P Anand","year":"2022","unstructured":"Anand P, Katyal J, Dey AB, Gupta YK. Characterization of potentially inappropriate medications use in Indian elderly population and their impact on quality of life using Beers criteria. Aging Med. 2022;5(1):45\u201352.","journal-title":"Aging Med"},{"issue":"1","key":"4381_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-019-1168-1","volume":"19","author":"TM Alhawassi","year":"2019","unstructured":"Alhawassi TM, Alatawi W, Alwhaibi M. Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria. BMC Geriatr. 2019;19(1):1\u20138.","journal-title":"BMC Geriatr"},{"key":"4381_CR45","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s11096-012-9656-9","volume":"34","author":"MG Oliveira","year":"2012","unstructured":"Oliveira MG, Amorim WW, de Jesus SR, Rodrigues VA, Passos LC. Factors associated with potentially inappropriate medication use by the elderly in the Brazilian primary care setting. Int J Clin Pharm. 2012;34:626\u201332.","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"4381_CR46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.archger.2010.11.017","volume":"53","author":"Y-J Lin","year":"2011","unstructured":"Lin Y-J, Peng L-N, Chen L-K, Lin M-H, Hwang S-J. Risk factors of potentially inappropriate medications among older patients visiting the community health center in rural Taiwan. Arch Gerontol Geriatr. 2011;53(2):225\u201328.","journal-title":"Arch Gerontol Geriatr"},{"key":"4381_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-018-3827-x","volume":"19","author":"H Luo","year":"2019","unstructured":"Luo H, Fan Q, Bian T, Li X, Chen K, Zhang Q, et al. Awareness, attitude and behavior regarding Proton pump inhibitor among medical staff in the Southwest of China. BMC Health Serv Res. 2019;19:1\u20139.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"4381_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-017-0164-3","volume":"18","author":"V Alves-Concei\u00e7\u00e3o","year":"2017","unstructured":"Alves-Concei\u00e7\u00e3o V, Silva DTd S, VLd S, EGd, Santos LMC, Lyra DP. Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study. BMC Pharmacol Toxicol. 2017;18(1):1\u20138.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"4381_CR49","doi-asserted-by":"crossref","first-page":"e0216805","DOI":"10.1371\/journal.pone.0216805","volume":"14","author":"S Lee","year":"2019","unstructured":"Lee S, Jang J, Yang S, Hahn J, Min KL, Jung E, et al. Development and validation of the Korean version of the medication regimen complexity index. PLoS ONE. 2019;14(5):e0216805.","journal-title":"PLoS One"},{"key":"4381_CR50","doi-asserted-by":"crossref","unstructured":"Ferreira JM, Galato D, Melo AC. Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities. Pharm Pract. 2015;13(4).","DOI":"10.18549\/PharmPract.2015.04.659"},{"issue":"6","key":"4381_CR51","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/ggi.13261","volume":"18","author":"LL Pantuzza","year":"2018","unstructured":"Pantuzza LL, Ceccato MGB, Silveira MR, Pinto IV, Reis AMM. Validation and standardization of the Brazilian version of the Medication Regimen Complexity Index for older adults in primary care. Geriatr Gerontol Int. 2018;18(6):853\u201359.","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"4381_CR52","first-page":"155","volume":"7","author":"JF Van Mil","year":"2006","unstructured":"Van Mil JF, Schulz M. A review of pharmaceutical care in community pharmacy in Europe. Harv Health Policy Rev. 2006;7(1):155\u201368.","journal-title":"Harv Health Policy Rev"},{"issue":"1","key":"4381_CR53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17827\/aktd.405358","volume":"28","author":"Y Erg\u00fcn","year":"2019","unstructured":"Erg\u00fcn Y, Aykan DA. Ak\u0131lc\u0131 \u0130la\u00e7 Kullan\u0131m\u0131nda Genel \u0130lkeler. Ar\u015fiv Kaynak Tarama Derg. 2019;28(1):19\u201327.","journal-title":"Ar\u015fiv Kaynak Tarama Derg"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-023-04381-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-023-04381-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-023-04381-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:20:09Z","timestamp":1700623209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-023-04381-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4381"],"URL":"https:\/\/doi.org\/10.1186\/s12877-023-04381-4","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"11 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval of the study was obtained from the Suleyman Demirel Clinical Research Ethics Committee (Approval No: 196 Date: 07.07.2022). We confirm that all methods were performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"655"}}